Search results for: 'Veterinary Diagnostics Market'
- Related search terms
- Markets & Markets, Synthetic Biology – Global forecast to 2027, 2023. 01
- marketing strategy homes industry year 16.9
- marketing strateg homes industry year 1.09
- market analysi of rf energy harvesting technolog
- marketing strateg homes industry year 16.9
-
30 Sep 2015  |  North America  |  Market Research
Analysis of the Cardiac Biomarker Diagnostics Market
Emerging Biomarkers Disrupt and Spur Growth in the Heart Failure Segment
The cardiac biomarker diagnostics market is a niche but upcoming space in the United States. With regulations favoring personalized medicine and diagnostics, large companies are focusing their investment in researching and detecting new biomarkers to differentiate their products in this competitive market. In addition to growing prevalence rates th...
$4,950.00
Special Price $3,712.50 save 25 %
-
14 Jan 2019  |  North America  |  Market Research
Growth Opportunities in the Global qPCR and dPCR Market, Forecast to 2023
Novel Applications in Oncology and Applied Sciences, Growing Research and Diagnostic Use in Developing Regions, and Automated Modular Workflows to Drive Growth
Overview: PCR continues to be the gold standard for nucleic acid amplification by combining accuracy and efficacy that users across areas such as research, pharma & biotech, diagnostics as well as applied sciences depend upon. Such widespread usage continues to drive the industry, even protecting it to some extent from overall economic/market fluct...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Jul 2017  |  North America  |  Market Research
US Oncology Diagnostics Market, Forecast to 2021
Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection
Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consolida...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Jun 2014  |  Europe  |  Market Research
Western Europe In Vitro Diagnostics (IVD) Market Data
Poor Reimbursement Rates Affect the Growth of Promising IVD Segments
This study provides data for the Western European in vitro diagnostics (IVD) market. Haematology, haemostasis, urinalysis, microbiology, clinical chemistry, point-of-care testing, molecular diagnostics, tissue diagnostics, self-monitoring blood glucose and immunochemistry are the segments within this market. Market revenues have been included in th...
$3,950.00
Special Price $2,962.50 save 25 %
-
08 Feb 2023  |  North America  |  Market Research
Growth Opportunities in the Global Cloud-based Medical Imaging Informatics Market, Forecast to 2026
Conventional Medical Imaging Informatics Shifts to AI-based Consolidated Solutions
Medical imaging informatics solution deployment is shifting from the on-premises model to a cloud-based infrastructure. The conventional on-premises model, which requires every enterprise to buy, operate, and maintain its own cumbersome IT infrastructure and solutions, proves unsustainable in the era of big data. It is also short-sighted given the ...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Aug 2022  |  North America  |  Frost Radar
Frost Radar™: US Liquid Biopsy, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...
$4,950.00
Special Price $3,712.50 save 25 %
-
21 Mar 2011  |  Asia Pacific  |  Market Research
In-vitro Diagnostics Market Outlook in Australia
This research service analyzes the IVD market in Australia strategically by evaluating the various forces that are currently influencing this market. It analyzes the revenue potential for the key segments in this market, namely clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, self-monitoring of blood gl...
$4,950.00
Special Price $3,712.50 save 25 %
-
14 Aug 2020  |  Global  |  Technology Research
Pipeline Analysis of Phase III Medical Diagnostic Devices: The Potential Game Changers and Growth Enablers
Lightweight, Portable, Sensor and Artificial Intelligence-based Medical Devices Re-defining Diagnostic Scenario in Healthcare
This growth opportunity-technology (GO-TE) study identifies and analyzes some of the key developments in diagnostic medical devices across major therapeutic areas such as cardiology, neurology, and oncology. The research highlights the breakthrough diagnostic medical device technologies that are likely to be approved in the next 2-3 years. These pr...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Sep 2026  |  Global  |  Market Research
Growth Impact of AI on the Communication Test Equipment Market, 2025–2030
Use of AI for Diagnostics and Predictive Analytics is Driving Transformational Growth
Artificial intelligence (AI) is reshaping the global communication test equipment market by transforming product development, enabling intelligent and automated testing, and driving demand through next-generation communication infrastructure. This Frost & Sullivan analysis examines AI's impact across the communication test equipment value chain, fr...
$2,450.00 -
08 Nov 2016  |  North America  |  Market Research
The US Molecular Diagnostics Market, Forecast to 2021
Polymerase Chain Reaction (PCR) Holds Close to 53% Share but Strong Clinical Research will Push NGS to Revolutionize this Space in the Next 5 to 10 Ye
The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...
$4,950.00
Special Price $3,712.50 save 25 %